|
|
|
|
|
by nynx
1630 days ago
|
|
I hope we can eventually have self-contained machines that can synthesize many different types of medications. By certifying the machines or testing them thoroughly, you can lessen the worry that people will synthesize the drugs wrong. I think this is almost possible for a large range of simple, small-molecule drugs. |
|
For example, better quality insulin is far more expensive because there's tremendous capture not only in the insulin market but the bioreactors required to make the insulin from bacteria. The process isn't insanely complicated, chemistry-wise, but the fact that only a few can make it and its MUCH better means they can charge more.
Another example is one-off drugs for rare but potentially curable conditions. They are often so expensive that they're pulled from the market because 1% of 1% of the population needs them and you can't use that to drive revenue.
3D printing took off precisely because of the LACK of regulatory capture. Imagine you had an FDA synthesizer that could make something common and simple like blood pressure medication for fractional cents on the dollar. You wouldn't be able to find the plans for this like you could for a 3D printed gun, for example, because the technology requires actual expertise to use. So you'd likely be left buying it from some biotech firm who will happily charge a price equivalent to a lifetime supply of all the drugs it can produce. You once again reach the affordability problem. Not because the technology is that far out of reach or so esoteric, but to be able to even get the device into the people's homes who need it you would need to find centuries of deeply entrenched and well capitalized special interests. Pharma would rather you die from something preventable than leave a single penny uncollected. Normally this would be considered hyperbole but in this case it's absolutely, verifiably true.
You can be certain if any DIY "3d molecule printer" ever took off there would be heavily armed alphabet soup boys at the DEA ready to kill whoever to keep the interests of big pharma in power.